Noa Gross Even-Zohar

CD24 Is a Prognostic Marker for Multiple Myeloma Progression and Survival

M. Pick, M. Gatt, B. Nachmias, 2022, Journal of clinical medicine.

The Emerging Role of Venetoclax-Based Treatments in Acute Lymphoblastic Leukemia

S. Aumann, V. Vainstein, B. Nachmias, 2022, International journal of molecular sciences.

Re-induction versus salvage for D14-resiudal acute myeloid leukemia: A retrospective multi-center study.

A. Gural, Y. Ofran, Eran Zimran, 2022, Leukemia research.

Understanding the Bioactivity and Prognostic Implication of Commonly Used Surface Antigens in Multiple Myeloma

M. Pick, M. Gatt, B. Nachmias, 2022, Journal of clinical medicine.